This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...

Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can ...

HIV/AIDS patients challenging CVS Pharmacy Inc.'s policy of distributing specialty drugs through the mail failed to secure ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young HIV patients achieve medication adherence and undetectable viral loads.

Infectious disease clinicians raised alarm that proposed cuts to Medicaid could affect ID-related services, not only among ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

What is the history of the AIDS epidemic, when did treatment become widely available, and what are the current goals for ending this epidemic?

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

An existing drug for HIV could double as a preventative therapy ... the findings of our study are an association between this class of drugs and the development of Alzheimer's disease," Ambati ...

Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease.

Share on Pinterest New research suggests that HIV drugs may have a protective effect against Alzheimer’s. Willie B. Thomas/Getty Images Researchers at UVA Health have found that a class of HIV ...